BridgeBio Oncology Therapeutics, Inc. (BBOT) Insider Trading

Name: BridgeBio Oncology Therapeutics, Inc. (BBOT) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 14, 2026): Cobo Marc (Principal Accounting Officer): Grant/Award of 9,038 shares.

Get alerted when insiders trade BBOT

Email address

Loading company data...

Beta

Loading company details...

Beta